Antrix-Devas: Ex-ISRO chief Madhavan Nair summoned as accusedThe CBI had earlier informed the court that sanction to prosecute the former public servants had been obtained from the authorities concern...
16 Sep, 2017, 10.25 PM IST
Antrix-Devas deal: Court to take cognisance of charge sheetThe agency had on August 11 last year filed a charge sheet against the accused, alleging they had caused a loss of Rs 578 crore to the exch...
20 Aug, 2017, 11.50 AM IST
CBI has a month to get sanction to prosecute ex Department of Space officialThe CBI had filed an FIR against Nair and others accusing them of facilitating "wrongful" gain of Rs 578 crore to private multi-media compa...
07 Aug, 2017, 05.52 PM IST
Sanction to prosecute ex-ISRO chairman received: CBI to courtSpecial Judge Virender Kumar Goyal took CBI's submission on record after it was told that the agency has received the sanction to prosecute...
01 May, 2017, 11.08 PM IST
Court gives CBI 3 months to get sanction to prosecute ex-ISRO officialsIt was alleged in the FIR that the lease was given in violation of rules causing undue gain of Rs 578 crore to Devas Multimedia and corresp...
01 Feb, 2017, 04.43 PM IST
Bureaucratic reshuffle: 11 new joint secretaries appointedA total of 11 officers have been appointed as Joint Secretaries to various central government ministries as part of mid-level bureaucratic ...
22 Jan, 2016, 09.19 PM IST
Infosys had bet on transformational value of tech, services"When we started Infosys, we had placed two major bets. One was on tech becoming ubiquitous and the other was on services industry becoming...
16 Apr, 2014, 04.22 PM IST
SC ruling on Novartis victory of humanity over commercial consideration: Bhaskar Narayana, Natco PharmaNovartis has been selling it at international prices all over the world and whatever price it sells in the US, it sells at the same price i...
01 Apr, 2013, 12.41 PM IST
Novartis tanks 7%, hits 52-week low as SC denies cancer drug patentOther pharmaceutical companies like Natco Pharma, Cipla and Ranbaxy surged 2-5% after the SC denied patent for Novartis' cancer drug Glivec.
01 Apr, 2013, 12.38 PM IST
- Intellectual board upholds CL to Natco for cancer drug
The IPAB has upheld the compulsory licence issued to Natco Pharma for production and marketing of generic version of cancer drug Nexavar.
05 Mar, 2013, 09.11 PM IST
Will continue selling Nexavar drug post IPAB verdict: Bhaskar Narayana, Natco PharmaIn an interview with ET Now, Bhaskar Narayana, Finance-Director, Natco Pharma, talks about the IPAB’s verdict on Natco’s cancer drug case a...
05 Mar, 2013, 04.06 PM IST
- IPAB allows Natco Pharma to sell Nexavar; stock gains
'Company will continue to market and sell the drug post verdict. It sold Rs 14 crore worth of Nexavar drug in the past 9 months.'
05 Mar, 2013, 10.54 AM IST
- West Bengal government to unveil incentive policy for IT sector
The West Bengal government would soon unveil a new incentive policy for the IT sector in the state.
08 Aug, 2012, 07.23 PM IST
- Natco, Mylan to appeal against New York district court verdict
The decision by the US court covers several patents for the chemical composition of Copaxone, methods of using the product and processes fo...
25 Jun, 2012, 08.47 PM IST
Pharma MNCs GSK, Merck, Pfizer and others prefer tie-ups over acquisitions with Indian firmsWith Indian drug makers flooding the developed markets, GSK, Merck, Pfizer now prefer tie-ups over acquisitions with Indian players.
02 May, 2012, 03.09 AM IST
Sree Padmanabha Swamy temple: Let temple riches be where they are, says ChandyThe Oommen Chandy government may have found it politically expedient to ensure the state keeps off the wealth and allow it to remain with t...
05 Jul, 2011, 12.23 PM IST
- K’taka govt says case registered against Murthy, police say no
In a new twist to the national anthem row involving Infosys chief mentor NR Narayana Murthy, the Mysore police on Friday maintained they ha...
14 Apr, 2007, 02.38 AM IST